Treatment of HAE Attacks with Anticipated Future Oral On-Demand Therapies as Reported by Patients

Valerieva A, Jones D, van Kooten S, Malloy N, Heckmann M, Betschel S
EAACI 2024

Patient-Reported Benefits of Early On-Demand Treatment of HAE Attacks

Longhurst H, Guilarte M, van Kooten S, Malloy N, Heckmann M, Busse P
EAACI 2024

A sensitive and specific assay to characterize plasma kallikrein activity in plasma from hereditary angioedema patients

Lee D, Ghannam A, Murugesan N, Vincent D, Mogg A, Smith M, Hampton S, Feener E
EAACI 2024

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Savic S, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya P, Yong P
EAACI 2024

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks

Yong P, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya P, Savic S
EAACI 2024

Unmet Needs Associated with Non-androgen Injectable Long-term Prophylaxis (LTP) Therapies for HAE

Lumry W, Baptist A, Soteres D, Manning M, Wynne-Cattanach K, Birija L, Audhya PK, Wang A, Andriotti T, Desai V
EAACI 2024

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results

Cohn DM
EAACI 2024

Trends in Volume of On-demand Hereditary Angioedema Treatments in the US: A Retrospective Analysis of a Large Multi-payer Claims Database

Soteres DF, Maheshwari C, Sharma A, Wang A, Audhya PK, Tachdjian R
EAC 2024

Real-world Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

Craig T, Busse P, Christiansen S, O’Connor M, Radojicic C, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V
EAC 2024

Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis

Tachdjian R, Soteres D, Chang R, Mohan M, Pinaire M, DerSarkissian M, Desai V, Wang A, Audhya P
EAC 2024

About

Management team

Board of Directors

Science

Pipeline

Sebetralstat

Oral Factor XIIa Inhibitor

Careers

Job Openings

Contact

KalVista Terms of Use Privacy Policy
© 2024 KalVista Pharmaceuticals. All Rights Reserved.